Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

NCT02639091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Medical Oncology

Interventions

DRUG: BAY 94-9343
DRUG: Pemetrexed
DRUG: Cisplatin

Sponsor

Bayer